ABCG1
Basic information
Region (hg38): 21:42199689-42304389
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 7 | |||||
Total | 0 | 0 | 20 | 9 | 15 |
Variants in ABCG1
This is a list of pathogenic ClinVar variants found in the ABCG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-42201687-G-A | ABCG1-related disorder | Benign (Dec 06, 2019) | ||
21-42201697-A-G | not specified | Uncertain significance (Oct 14, 2021) | ||
21-42219222-CCCG-C | ABCG1-related disorder | Benign (Feb 19, 2019) | ||
21-42219222-CCCGCCG-C | ABCG1-related disorder | Benign (May 24, 2019) | ||
21-42219222-CCCGCCGCCGCCG-C | ABCG1-related disorder | Benign (Sep 05, 2019) | ||
21-42219222-CCCGCCGCCGCCGCCG-C | ABCG1-related disorder | Likely benign (Apr 25, 2019) | ||
21-42219222-C-CCCG | ABCG1-related disorder | Benign (May 22, 2019) | ||
21-42219222-C-CCCGCCG | ABCG1-related disorder | Benign (Nov 21, 2019) | ||
21-42219222-C-CCCGCCGCCGCCGCCG | ABCG1-related disorder | Benign (Jan 08, 2020) | ||
21-42219271-T-C | ABCG1-related disorder | Benign (Feb 19, 2019) | ||
21-42225699-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
21-42225734-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
21-42225765-C-T | not specified | Uncertain significance (Jul 27, 2022) | ||
21-42225766-G-A | ABCG1-related disorder | Likely benign (May 30, 2019) | ||
21-42225811-G-A | ABCG1-related disorder | Likely benign (Oct 07, 2019) | ||
21-42225852-T-G | not specified | Uncertain significance (Apr 01, 2024) | ||
21-42225918-G-A | ABCG1-related disorder | Benign (Jul 27, 2018) | ||
21-42271122-G-A | ABCG1-related disorder | Benign (Aug 15, 2019) | ||
21-42271132-A-C | not specified | Uncertain significance (Jan 24, 2024) | ||
21-42273345-C-G | ABCG1-related disorder | Benign (Jun 15, 2018) | ||
21-42273407-C-T | not specified | Uncertain significance (May 27, 2022) | ||
21-42276889-C-T | ABCG1-related disorder | Benign (Jul 12, 2019) | ||
21-42282294-G-A | ABCG1-related disorder | Likely benign (Feb 28, 2019) | ||
21-42282349-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
21-42282350-G-A | not specified | Uncertain significance (Apr 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCG1 | protein_coding | protein_coding | ENST00000361802 | 15 | 97556 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.112 | 0.888 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.13 | 309 | 434 | 0.712 | 0.0000278 | 4418 |
Missense in Polyphen | 50 | 96.098 | 0.5203 | 982 | ||
Synonymous | 0.423 | 189 | 197 | 0.962 | 0.0000144 | 1381 |
Loss of Function | 3.86 | 8 | 31.3 | 0.256 | 0.00000143 | 369 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000272 | 0.000272 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000977 | 0.0000967 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000986 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transporter involved in macrophage lipid homeostasis. Is an active component of the macrophage lipid export complex. Could also be involved in intracellular lipid transport processes. The role in cellular lipid homeostasis may not be limited to macrophages.;
- Pathway
- ABC transporters - Homo sapiens (human);Nuclear Receptors in Lipid Metabolism and Toxicity;HDL remodeling;ABC transporters in lipid homeostasis;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;ABC-family proteins mediated transport;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling
(Consensus)
Recessive Scores
- pRec
- 0.437
Intolerance Scores
- loftool
- 0.410
- rvis_EVS
- -1.37
- rvis_percentile_EVS
- 4.43
Haploinsufficiency Scores
- pHI
- 0.0964
- hipred
- Y
- hipred_score
- 0.623
- ghis
- 0.488
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.517
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abcg1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;cholesterol metabolic process;detection of hormone stimulus;response to organic substance;negative regulation of macrophage derived foam cell differentiation;regulation of cholesterol esterification;positive regulation of cholesterol efflux;negative regulation of cholesterol storage;intracellular cholesterol transport;cholesterol efflux;phospholipid efflux;response to lipid;low-density lipoprotein particle remodeling;high-density lipoprotein particle remodeling;glycoprotein transport;cholesterol homeostasis;amyloid precursor protein catabolic process;reverse cholesterol transport;positive regulation of cholesterol biosynthetic process;transmembrane transport;phospholipid homeostasis;cellular response to high density lipoprotein particle stimulus;toxin transport
- Cellular component
- Golgi membrane;mitochondrion;endosome;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;external side of plasma membrane;integral component of membrane;recycling endosome
- Molecular function
- ATP binding;phospholipid binding;phospholipid transporter activity;cholesterol binding;cholesterol transporter activity;toxin transmembrane transporter activity;sterol-transporting ATPase activity;glycoprotein transporter activity;ATPase activity, coupled to transmembrane movement of substances;protein homodimerization activity;ADP binding;protein heterodimerization activity;protein dimerization activity